The largest database of trusted experimental protocols

12 protocols using penicillin g

1

Evaluating Anti-Cancer Effects of P. quercetorum Extract

Check if the same lab product or an alternative is used in the 5 most similar protocols
Non-small cell lung cancer cell lines A549, H1299 (Dr Donner, Walther Oncology Center, Indiana University School of Medicine, Indianapolis, IN, USA) and PC3 (Dr Yokota, National Cancer Center Research Institute, Division of Genome Biology, Tokyo, Japan) were cultured in RPMI-1640 (Lonza Bioscience, Verviers, Belgium) medium supplemented with L-glutamine (Gibco®; Thermo Fisher Scientific, Inc., Waltham, MA, USA), 10% fetal bovine serum (Lonza Bioscience), penicillin G (100 U/ml) and streptomycin (100 µg/ml) (HyClone; GE Healthcare Life Sciences, Logan, UT, USA) at 37°C in a humidified atmosphere containing 5% CO2. According to the American Type Culture Collection (Manassas, VA, USA), PC3 is often known as a prostate cancer cell line (CRL1435), but in the present study, it represents a non-small cell lung cancer cell line derived from the Japanese Collection Research Resources Bank (Osaka, Japan; JCRB, JCRB0077).
The lyophilized P. quercetorum extract (PQE) was dissolved in dimethyl sulfoxide (DMSO; Sigma-Aldrich, St. Louis, MO, USA) at a concentration of 100 mg/ml as a stock solution, aliquoted and stored at −80°C. PQE was used at different concentrations ranging from 3.13 to 100 µg/ml, and the dilutions were made in culture medium.
+ Open protocol
+ Expand
2

Measuring Hypertrophic Differentiation via ALP

Check if the same lab product or an alternative is used in the 5 most similar protocols
ALP is one of the most common indicators of hypertrophic differentiation, and was measured in culture supernatants as described previously (11 (link)). At 7, 14 and 21 days, the medium was replaced with phenol red-free DMEM supplemented with 10% fetal bovine serum, 10 U/ml penicillin G and 10 mg/ml streptomycin (GE Healthcare Life Sciences). Supernatants was collected after 1 day and centrifuged at 1,400 × g for 10 min at 4°C to remove particles. ALP activity was immediately assayed using a commercial ALP kit (Nanjing Jiancheng Bioengineering Institute, Nanjing, China) according to the manufacturer's protocol.
+ Open protocol
+ Expand
3

Isolation and Characterization of Rat BMSCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
OriCell™ Sprague-Dawley rat BMSCs (catalog no. RASMX-01001) were purchased from Cyagen Biosciences Inc. (Guangzhou, China). Cell viability, sterility, purity, proliferation and differentiation ability were tested by the company, which revealed that cells were highly positive for the specific mesenchymal markers CD29 (83.99%), CD44 (99.69%) and CD90 (95.05%), and negative for the hematopoietic cell-surface markers CD34 (0.62%), CD45 (0.28%), and CD11b (4.25%). To verify pluripotency, BMSCs were able to differentiate into osteoblasts, chondrocytes and adipocytes. Cells were thawed at 37°C in a water bath and resuspended in low glucose Dulbecco's modified Eagle's medium (LG-DMEM) supplemented with 10% fetal bovine serum, 10 U/ml penicillin G and 10 mg/ml streptomycin, all purchased from Hyclone (GE Healthcare Life Sciences, Logan, UT, USA). The cell suspension was subsequently plated into T25 flasks and incubated in a 5% carbon dioxide humidified incubator at 37°C. Upon achieving 80–90% confluence, cells were treated with 0.25% trypsin/1 mM ethylenediaminetetraacetic acid (Gibco; Thermo Fisher Scientific, Inc., Waltham, MA, USA) for 3–5 min. In order to harvest an adequate number of cells, cells at passage 5 to 7 were used in this study.
+ Open protocol
+ Expand
4

Phytochemical analysis of P. alkekengi var. franchetii

Check if the same lab product or an alternative is used in the 5 most similar protocols
The fruit calyxes of P. alkekengi var. franchetii collected in Icheon-si, Kyeonggi-do, Korea were purchased from Chodamchae Co. (Gunpo-si, Kyeonggi-do, Korea), in February 2011 and identified by one of the authors, Prof. Insop Shim (Kyung Hee University, Seoul 130-701, Korea). A voucher specimen (No. EA325) has been deposited at the College of Pharmacy, Ewha Woman’s University. Mouse macrophage RAW 264.7 cells were obtained from the Korean Cell Line Bank (Seoul, Korea). Dulbeco’s Modified Eagle’s Medium; fetal bovine serum (Hyclone; GE Healthcare Life Sciences, Logan, UT, USA); penicillin G (GE Healthcare Life Sciences, Logan, UT, USA); streptomycin (GE Healthcare Life Sciences, Logan, UT, USA); RP-18 F 254s (Merck, Darmstadt, Germany) plates; Kieselgel 60 F 254 (silica gel, 0.25 mm layer thickness, Merck, Darmstadt, Germany); TRIzol reagent (Gibco-BRL Life Technologies; Thermo Fisher Scientific, Inc., Waltham, MA, USA); Taq polymerase (TaKaRa Co., Kusatsu, Shiga, Japan); SYBR green master mix (Invitrogen, Carlsbad, CA, USA).
+ Open protocol
+ Expand
5

Cell Culture and Hypoxia Exposure

Check if the same lab product or an alternative is used in the 5 most similar protocols
All cell lines were grown in RPMI-1640 or DMEM (GE Healthcare) supplemented with 10% fetal bovine serum (Sigma-Aldrich) and 100 U/ml penicillin G and 100 μg/ml streptomycin (GE Healthcare) at 37°C under 5% CO2. For hypoxia experiments, 24 hours after cell seeding cells were incubated at 37°C for indicated times in a sealed hypoxia chamber filled with 1% O2, 4% CO2 and 95% N2.
+ Open protocol
+ Expand
6

Assessing Rheumatoid Arthritis T Cell Responses

Check if the same lab product or an alternative is used in the 5 most similar protocols
Venous blood (obtained from RA patients or healthy donors) was collected in heparinized tubes. All patients met the American Rheumatism Association criteria (1987) for RA. The characteristics of RA patients are summarized in supplement 1. The study protocol was approved by the responsible local administrative body and ethics committee of Charité University Medicine Berlin in accordance with the Declaration of Helsinki. RA patients as well as healthy donors provided written informed consent before enrolment. Human CD4+ T cells (>99% purity and >95% viability) were prepared as described previously 26 . Cells were resuspended in RPMI 1640 (GIBCO) supplemented with 10% (v/v) heat-inactivated fetal calf serum (Sigma-Aldrich), 100 units/ml penicillin G, 100 µg/ml streptomycin (both PAA Laboratories GmbH, Cölbe, Germany) and 50µM β-mercaptoethanol (Sigma-Aldrich).
Cells were stimulated with the mitogen PHA-L (5µg/ml) and/or a-PVA-SPION (1 µg/ml, 10 µg/ml, and 100 µg/ml) or left untreated for 20 h (analysis of caspase-3/7-activity (Caspase-Glo 3/7 Assay, Promega GmbH, Mannheim, Germany), intracellular ATP content and CD25 expression) or 72 h (analysis of proliferation and CD25 expression). Cells were incubated at 37°C under either normoxia (18% O2 / 5% CO2) and/or in a hypoxic chamber (5% CO2 / ≤1% O2) balanced with N2 in humidified incubators (both Binder GmbH, Tuttlingen, Germany).
+ Open protocol
+ Expand
7

C2C12 Myoblast Differentiation and Osteogenesis

Check if the same lab product or an alternative is used in the 5 most similar protocols
C2C12 cells (ATCC® CRL-1772™, <20 passages) were maintained in polystyrene flasks in a 37°C, 5% CO2 incubator and cultured in growth medium (GM [1:1 Dulbecco’s Modified Eagle Medium (DMEM):F12 medium (11320-074, Invitrogen), 10% fetal bovine serum (FBS, 10270-098, Invitrogen), 10 U/mL penicillin G and 10 μg/ml streptomycin (15140-122, Invitrogen). Cells were subcultured prior to reaching 60%–70% confluence. For all experiments, C2C12 cells were seeded at 30,000 cells/cm2 in GM until confluency (D0), when the medium was switched in differentiation medium (DM) (1:1 DMEM:F12 with 2% horse serum (HS from PAA Laboratories), 10 U/mL penicillin G and 10 μg/ml streptomycin as previously described (Ren et al., 2008 (link)). For the kinetics analysis of gene expression followed by qPCR, DM was refreshed at day 3 (D3) and day 5 (D5). Soluble BMP-2 (sBMP-2) was added in the GM at 600 ng/ml and refreshed at each change of medium until D5 (Figure 1A). Their translocations to the nucleus were observed by immunofluorescence at D0 for osterix, and at D1 and D3 for myogenin and MyoD, respectively. In addition, the ability of bBMP-2 films to induce later osteogenesis was confirmed by following the gene expression of Osteocalcin and by verifying cell mineralization.
+ Open protocol
+ Expand
8

Cell Line Cultivation Protocols

Check if the same lab product or an alternative is used in the 5 most similar protocols
African green monkey kidney fibroblasts (CV-1) and the human primary glioblastoma cell line U87-MG were obtained from the American Type Culture Collection (ATCC). IMA2.1 cells were obtained from S. Schildknecht (University of Konstanz, Germany). These cells are immortalized murine cortical astrocytes that respond to certain stimuli similarly to primary astrocytes with upregulation of specific mRNA resulting in expression of proteins [37 (link)]. BV-2 cells were kindly provided by M. Karlstetter (University Hospital Cologne, Germany). This cell line was derived from raf/myc-immortalized murine neonatal microglia and is the most frequently used substitute for primary microglia [38 (link)–40 (link)]. The murine glioblastoma cell line GL261 was kindly provided by A. Pagenstecher (Department of Neuropathology, University Hospital of Marburg, Germany). The identity of GL261 cells was confirmed by DNA sequencing by the Leibniz Institute DSMZ—German Collection of Microorganisms and Cell Cultures (Braunschweig, Germany).
All cell lines were cultured in DMEM supplemented with antibiotic-solutions (100 U/ml penicillin G, 100 U/ml streptomycin, PAA Laboratories, Pasching, Austria) and with 10% fetal bovine serum (FBS; PAA Laboratories). Cultures were maintained and incubated at 37°C with 95% humidity and 5% CO2. Growth medium was changed every third day until confluence.
+ Open protocol
+ Expand
9

Whole Blood Cytokine Profiling in RA

Check if the same lab product or an alternative is used in the 5 most similar protocols
Venous blood (obtained from RA patients or HD) was collected in heparinized tubes. All patients met the American Rheumatism Association criteria (1987) for RA.59 The characteristics of RA patients are summarized in Table S1. The study protocol was approved by the responsible local administrative body and ethics committee. RA patients as well as HD provided written informed consent before enrollment.
Immediately after retrieval of the blood samples, 100 μL of whole blood was diluted with 100 μL Roswell Park Memorial Institute (RPMI) 1640 culture medium (Thermo Fisher Scientific, Waltham, MA, USA) supplemented with 100 U/mL penicillinG, 100 μg/mL streptomycin (both from PAA Laboratories) and 50 μM β-mercaptoethanol (Sigma-Aldrich Co.) in deep-well-plates (Sarstedt AG & Co., Nuembrecht, Germany). Cells were stimulated with LPS (1 μg/mL), PHA (5 μg/mL), a-PVA-SPION (1 μg/mL, 10 μg/mL, 100 μg/mL, 1,000 μg/mL) or left untreated and incubated for 20 hours in a humidified incubator at 37°C (18% O2/5% CO2). Afterwards, supernatants were collected, immediately frozen, and stored at −80°C for cytokine secretion analysis and cells were prepared for flow cytometry (see section Flow cytometric analysis). For intracellular IL1β analysis, secretion was blocked by adding 10 μg/mL Brefeldin A followed by an additional incubation for 3 hours at 37°C.
+ Open protocol
+ Expand
10

Isolation and Expansion of Human Articular Chondrocytes

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human articular chondrocytes (hCh; n = 6) were isolated from femoral heads of patients (mean = 70.3 ± 5.3 years) undergoing hip replacement surgery (ethical approval was obtained of the University Kiel D572/17). The cartilage tissue was dissected into small pieces and digested with 0.1% pronase (Roche, Mannheim, Germany) followed by digestion with type 2 collagenase 600 U/ml (Worthington, Lakewood, USA) in Dulbecco’s Modified Eagle Medium (DMEM). Isolated hCh were cultured at a density of 10,000 cells/cm2 in chondropermissive medium (CPM) consisting of high-glucose DMEM (HG-DMEM) supplemented with 10% Sera Plus (PAN-Biotech, Aidenbach, Germany), 10 mg/ml Penicillin G, 10 mg/ml of streptomycin (PAA Laboratories, Pasching, Germany),1% L-ascorbic acid (Sigma-Aldrich, St. Louis, USA) and 2 ng/ml fibroblastic growth factor–2 (FGF-2; R&D Systems, Minneapolis, USA). Medium change was twice a week. Cells were harvested at cell passage 3 (P3) by trypsin–ethylenediaminetetraacetic acid (EDTA; Lonza, Cologne, Germany) treatment and used for further in vitro cultivation.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!